GHRH analog FDA-approved for visceral fat reduction. Clinical data to 52 weeks. Targets deep abdominal fat specifically while optimizing GH. The most evidence-backed fat-targeting peptide.
Tap dots for details. Scroll horizontally to see full timeline.
“Fat loss didn't show until week 10 but then was unmistakable.”
“Belt on next notch. Scale barely moved.”
“Week 12, waist down 2 inches. Nothing else changed.”
“More visceral-specific than anything I've used. The deep belly fat.”
2mg SubQ daily. Do not combine with CJC/Ipa (both stimulate GH).